BLACK DIAMOND THERAPEUTICS
BDTX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-01-30
2025-01-31
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
175K
$0.00
1
$132.49M
2025-01-30
2025-01-31
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Common Stock
75,000
$0.00
1
$132.49M
2025-01-30
2025-01-31
HATZIS-SCHOCH BRENT
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
175K
$0.00
1
$132.49M
2025-01-30
2025-01-31
JONES ERIKA
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$132.49M
2025-01-30
2025-01-31
YURASOV SERGEY
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
75,000
$0.00
1
$132.49M
2025-01-30
2025-01-31
HATZIS-SCHOCH BRENT
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
175K
$0.00
1
$132.49M
2025-01-30
2025-01-31
YURASOV SERGEY
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
75,000
$0.00
1
$132.49M
2025-01-30
2025-01-31
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Common Stock
75,000
$0.00
1
$132.49M
2025-01-30
2025-01-31
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
175K
$0.00
1
$132.49M
2025-01-30
2025-01-31
VELLECA MARK
PRESIDENT & CEO
A - Grant
Stock Option (Right to Buy)
500K
$0.00
1
$132.49M
2025-01-30
2025-01-31
YURASOV SERGEY
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$132.49M
2025-01-30
2025-01-31
JONES ERIKA
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$132.49M
2025-01-30
2025-01-31
VELLECA MARK
PRESIDENT & CEO
A - Grant
Stock Option (Right to Buy)
500K
$0.00
1
$132.49M
2025-01-30
2025-01-31
YURASOV SERGEY
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$132.49M
2024-08-28
2024-08-30
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-222K
$6.00
-1.33M
1
$132.49M
2024-02-14
2024-02-15
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$132.49M
2024-02-14
2024-02-15
HATZIS-SCHOCH BRENT
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$132.49M
2024-02-14
2024-02-15
JONES ERIKA
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$132.49M
2024-02-14
2024-02-15
VELLECA MARK
PRESIDENT & CEO
A - Grant
Stock Option (Right to Buy)
537K
$0.00
1
$132.49M
2024-02-14
2024-02-15
YURASOV SERGEY
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
225K
$0.00
1
$132.49M
2023-09-17
2023-09-18
VELLECA MARK
PRESIDENT & CEO
A - Grant
Stock Option (Right to Buy)
1.00M
$0.00
1
$132.49M
2023-02-13
2023-02-15
EPSTEIN DAVID
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
420K
$0.00
1
$132.49M
2023-02-13
2023-02-15
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$132.49M
2023-02-13
2023-02-15
HATZIS-SCHOCH BRENT
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$132.49M
2023-02-13
2023-02-15
JONES ERIKA
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$132.49M
2023-02-13
2023-02-15
YURASOV SERGEY
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$132.49M
2022-06-10
2022-06-13
INGRAM ROBERT ALEXANDER
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$132.49M
2022-02-15
2022-02-17
BUCK ELIZABETH
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$132.49M
2022-02-15
2022-02-17
EPSTEIN DAVID
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$132.49M
2022-02-15
2022-02-17
HATZIS-SCHOCH BRENT
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$132.49M
2022-02-15
2022-02-17
JONES ERIKA
SEE REMARKS
A - Grant
Stock Option (Right to Buy)
20,300
$0.00
1
$132.49M
2021-06-18
2021-06-22
INGRAM ROBERT ALEXANDER
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$132.49M
2021-05-12
2021-05-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2021-05-12
2021-05-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2021-05-12
2021-05-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$27.00
-110K
3
$132.49M
2021-05-03
2021-05-05
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$27.00
-67,500
1
$132.49M
2021-05-03
2021-05-05
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2021-05-03
2021-05-05
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2021-04-12
2021-04-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-180K
$0.00
1
$132.49M
2021-04-12
2021-04-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2021-04-12
2021-04-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$25.00
-102K
1
$132.49M
2021-04-05
2021-04-07
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2021-04-05
2021-04-07
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2021-04-05
2021-04-07
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$26.00
-65,000
1
$132.49M
2021-03-12
2021-03-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2021-03-12
2021-03-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2021-03-12
2021-03-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$26.00
-106K
1
$132.49M
2021-03-03
2021-03-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$26.00
-65,000
2
$132.49M
2021-03-03
2021-03-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2021-03-03
2021-03-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2021-02-17
2021-02-19
EPSTEIN DAVID
Officer Title: President and C...
A - Grant
Stock Option (Right to Buy)
225K
$0.00
1
$132.49M
2021-02-17
2021-02-19
HATZIS-SCHOCH BRENT
Officer Title: Chief Operating...
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$132.49M
2021-02-17
2021-02-19
HUMPHREY RACHEL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$132.49M
2021-02-17
2021-02-19
LEGGETT THOMAS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$132.49M
2021-02-17
2021-02-19
ROBERTS CHRISTOPHER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$132.49M
2021-02-12
2021-02-12
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$27.00
-110K
2
$132.49M
2021-02-12
2021-02-12
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2021-02-12
2021-02-12
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2021-02-03
2021-02-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$25.00
-62,500
1
$132.49M
2021-02-03
2021-02-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2021-02-03
2021-02-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2021-01-12
2021-01-14
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
11,578
$8.00
92,624
2
$132.49M
2021-01-12
2021-01-14
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-11,578
$34.00
-394K
6
$132.49M
2021-01-12
2021-01-14
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-11,578
$0.00
2
$132.49M
2021-01-08
2021-01-11
LEGGETT THOMAS
Chief Financial Officer
S - Sale
Common Stock
-3,000
$34.00
-102K
1
$132.49M
2021-01-08
2021-01-11
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2021-01-08
2021-01-11
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Common Stock
3,000
$11.00
33,000
1
$132.49M
2021-01-04
2021-01-06
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2021-01-04
2021-01-06
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2021-01-04
2021-01-06
EPSTEIN DAVID
Officer Title: President and C...
S - Sale
Common Stock
-12,000
$31.00
-372K
2
$132.49M
2021-01-04
2021-01-06
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$31.00
-77,500
2
$132.49M
2021-01-04
2021-01-06
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2021-01-04
2021-01-06
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Common Stock
3,000
$6.00
18,000
1
$132.49M
2020-12-28
2020-12-29
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-5,400
$0.00
1
$132.49M
2020-12-28
2020-12-29
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
5,400
$3.00
16,200
1
$132.49M
2020-12-15
2020-12-16
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Common Stock
2,500
$6.00
15,000
1
$132.49M
2020-12-15
2020-12-16
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
3,200
$11.00
35,200
1
$132.49M
2020-12-15
2020-12-16
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2020-12-15
2020-12-16
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-3,200
$0.00
1
$132.49M
2020-12-14
2020-12-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$35.00
-143K
1
$132.49M
2020-12-14
2020-12-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2020-12-14
2020-12-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2020-12-08
2020-12-10
LEGGETT THOMAS
Chief Financial Officer
S - Sale
Common Stock
-3,000
$34.00
-102K
2
$132.49M
2020-12-08
2020-12-10
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-12-08
2020-12-10
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Common Stock
3,000
$11.00
33,000
1
$132.49M
2020-12-03
2020-12-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$32.00
-80,000
1
$132.49M
2020-12-03
2020-12-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2020-12-03
2020-12-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2020-12-01
2020-12-03
EPSTEIN DAVID
Officer Title: President and C...
S - Sale
Common Stock
-12,000
$33.00
-396K
2
$132.49M
2020-12-01
2020-12-03
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-12-01
2020-12-03
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Common Stock
3,000
$6.00
18,000
1
$132.49M
2020-11-30
2020-12-01
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-10,393
$33.00
-343K
2
$132.49M
2020-11-19
2020-11-23
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-130K
$33.00
-4.29M
2
$132.49M
2020-11-18
2020-11-19
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-536
$33.00
-17,688
2
$132.49M
2020-11-17
2020-11-19
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-4,194
$33.00
-138K
2
$132.49M
2020-11-16
2020-11-17
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-200
$33.00
-6,600
2
$132.49M
2020-11-13
2020-11-17
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-4,500
$34.00
-153K
4
$132.49M
2020-11-12
2020-11-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2020-11-12
2020-11-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2020-11-12
2020-11-13
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$34.00
-139K
3
$132.49M
2020-11-12
2020-11-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-15,598
$34.00
-530K
6
$132.49M
2020-11-11
2020-11-13
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-5,000
$35.00
-175K
1
$132.49M
2020-11-11
2020-11-13
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$132.49M
2020-11-11
2020-11-13
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
5,000
$11.00
55,000
1
$132.49M
2020-11-11
2020-11-12
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-12,617
$35.00
-442K
4
$132.49M
2020-11-10
2020-11-12
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-26,966
$34.00
-917K
4
$132.49M
2020-11-09
2020-11-12
LEGGETT THOMAS
Chief Financial Officer
S - Sale
Common Stock
-3,000
$33.00
-99,000
1
$132.49M
2020-11-09
2020-11-12
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-11-09
2020-11-12
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Common Stock
3,000
$11.00
33,000
1
$132.49M
2020-11-09
2020-11-10
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-6,300
$33.00
-208K
2
$132.49M
2020-11-06
2020-11-10
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-3,100
$33.00
-102K
2
$132.49M
2020-11-05
2020-11-06
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-8,848
$33.00
-292K
2
$132.49M
2020-11-04
2020-11-06
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-2,500
$33.00
-82,500
2
$132.49M
2020-11-03
2020-11-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$32.00
-80,000
1
$132.49M
2020-11-03
2020-11-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2020-11-03
2020-11-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2020-11-02
2020-11-03
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Common Stock
3,000
$6.00
18,000
1
$132.49M
2020-11-02
2020-11-03
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-11-02
2020-11-03
EPSTEIN DAVID
Officer Title: President and C...
S - Sale
Common Stock
-12,000
$31.00
-372K
2
$132.49M
2020-10-27
2020-10-28
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-800
$33.00
-26,400
2
$132.49M
2020-10-26
2020-10-28
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-8,103
$33.00
-267K
2
$132.49M
2020-10-19
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-4,233
$33.00
-140K
2
$132.49M
2020-10-16
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-8,713
$34.00
-296K
2
$132.49M
2020-10-15
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-2,800
$33.00
-92,400
2
$132.49M
2020-10-14
2020-10-15
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-5,501
$33.00
-182K
2
$132.49M
2020-10-13
2020-10-15
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-11,739
$33.00
-387K
2
$132.49M
2020-10-12
2020-10-14
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$33.00
-135K
2
$132.49M
2020-10-12
2020-10-14
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2020-10-12
2020-10-14
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2020-10-12
2020-10-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-400
$33.00
-13,200
2
$132.49M
2020-10-09
2020-10-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-3,800
$34.00
-129K
2
$132.49M
2020-10-08
2020-10-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-18,425
$33.00
-608K
4
$132.49M
2020-10-08
2020-10-09
LEGGETT THOMAS
Chief Financial Officer
S - Sale
Common Stock
-3,000
$34.00
-102K
1
$132.49M
2020-10-08
2020-10-09
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-10-08
2020-10-09
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Common Stock
3,000
$11.00
33,000
1
$132.49M
2020-10-07
2020-10-08
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-27,836
$34.00
-946K
2
$132.49M
2020-10-06
2020-10-08
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-18,090
$33.00
-597K
2
$132.49M
2020-10-05
2020-10-07
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2020-10-05
2020-10-07
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$31.00
-77,500
2
$132.49M
2020-10-05
2020-10-07
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2020-10-01
2020-10-02
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Common Stock
3,000
$6.00
18,000
1
$132.49M
2020-10-01
2020-10-02
EPSTEIN DAVID
Officer Title: President and C...
S - Sale
Common Stock
-12,000
$30.00
-360K
1
$132.49M
2020-10-01
2020-10-02
EPSTEIN DAVID
Officer Title: President and C...
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-09-25
2020-09-29
INGRAM ROBERT ALEXANDER
A - Grant
Stock Option (Right to Buy)
29,842
$0.00
1
$132.49M
2020-09-14
2020-09-16
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Common Stock
3,000
$11.00
33,000
1
$132.49M
2020-09-14
2020-09-16
LEGGETT THOMAS
Chief Financial Officer
S - Sale
Common Stock
-3,000
$31.00
-93,000
1
$132.49M
2020-09-14
2020-09-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
S - Sale
Common Stock
-4,078
$31.00
-126K
3
$132.49M
2020-09-14
2020-09-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Stock Option (Right to Buy)
-4,078
$0.00
1
$132.49M
2020-09-14
2020-09-16
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
M - Exercise
Common Stock
4,078
$3.00
12,234
1
$132.49M
2020-09-14
2020-09-16
LEGGETT THOMAS
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$132.49M
2020-09-08
2020-09-10
HUMPHREY RACHEL
Chief Medical Officer
A - Grant
Common Stock
10,000
$0.00
1
$132.49M
2020-09-08
2020-09-10
HUMPHREY RACHEL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$132.49M
2020-09-03
2020-09-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
2,500
$11.00
27,500
1
$132.49M
2020-09-03
2020-09-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-2,500
$30.00
-75,000
2
$132.49M
2020-09-03
2020-09-04
ROBERTS CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-2,500
$0.00
1
$132.49M
2020-08-11
2020-08-12
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-7,575
$33.00
-250K
2
$132.49M
2020-08-10
2020-08-12
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-6,217
$33.00
-205K
2
$132.49M
2020-02-03
2020-02-05
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series A Preferred Stock
-20M
3
$132.49M
2020-02-03
2020-02-05
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series B Preferred Stock
-3.94M
3
$132.49M
2020-02-03
2020-02-05
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series C Preferred Stock
-5.19M
4
$132.49M
2020-02-03
2020-02-05
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Series C Preferred Stock
-1.71M
$0.00
1
$132.49M
2020-02-03
2020-02-05
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Common Stock
568K
1
$132.49M
2020-02-03
2020-02-05
EPSTEIN DAVID
President and Chief Executive ...
C - Conversion
Common Stock
270K
3
$132.49M
2020-02-03
2020-02-05
EPSTEIN DAVID
President and Chief Executive ...
C - Conversion
Series A Preferred Stock
-802K
2
$132.49M
2020-02-03
2020-02-05
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
P - Purchase
Common Stock
3,000
$19.00
57,000
1
$132.49M
2020-02-03
2020-02-05
VERSANT VENTURE CAPITAL VI, L.P.
P - Purchase
Common Stock
895K
$19.00
17M
4
$132.49M
2020-02-03
2020-02-05
EPSTEIN DAVID
President and Chief Executive ...
C - Conversion
Series B Preferred Stock
-13,136
1
$132.49M
2020-01-29
2020-01-31
EPSTEIN DAVID
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
279K
$0.00
1
$132.49M
2020-01-29
2020-01-31
HATZIS-SCHOCH BRENT
Chief Operating Officer and Ge...
A - Grant
Stock Option (Right to Buy)
78,751
$0.00
1
$132.49M
2020-01-29
2020-01-31
LEGGETT THOMAS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
55,540
$0.00
1
$132.49M
2020-01-29
2020-01-31
ROBERTS CHRISTOPHER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
54,711
$0.00
1
$132.49M